Planta Med 2007; 73(7): 665-669
DOI: 10.1055/s-2007-981530
Pharmacology
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Cognition-Enhancing and Neuroprotective Effects of Hederacolchiside-E from Pulsatilla koreana

Chang-Kyun Han1 , 2 , Won Rack Choi1 , Ki-Bong Oh2
  • 1Life Science R&D Center, SK Chemicals, Changan-gu, Suwon-si, Gyeonggi-do, Korea
  • 2Department of Agricultural Biotechnology, Seoul National University, Seoul, Korea
Weitere Informationen

Publikationsverlauf

Received: December 19, 2006 Revised: April 16, 2007

Accepted: April 22, 2007

Publikationsdatum:
31. Mai 2007 (online)

Zoom Image

Abstract

The root extract of Pulsatilla koreana (Ranunculaceae) has been found to have prominent abilities to reverse scopolamine-induced cognitive impairment in rats, and to increase the viability of human neuroblastoma SK-N-SH cells incubated with amyloid-β peptide (1 - 42) [Aβ (1 - 42)]. In vivo and in vitro activity-guided fractionation studies using solvent-partitioning and subsequent chromatographic separations led to the isolation of hederacolchiside-E, an oleanolic glycoside, as an active ingredient. Administration of hederacolchiside-E (30 and 60 mg/kg body weight, p. o.) increased the step-through latency time in the passive avoidance test as efficiently as tacrine (30 mg/kg, p. o.). The neuroprotective effect of hederacolchiside-E on SK-N-SH cells against the toxicity of Aβ (1 - 42) was comparable to that of catechin. These data suggest that hederacolchiside-E might be a good therapeutic candidate for the treatment of Alzheimer’s disease.